Back to top

LIMN forms Stochastic Buy Signal on August 3

Liminatus Pharma, Inc. (LIMN) — SwingTradeBot Technical Analysis Report · Aug 3, 2026, 17:56 ET
LIMN finished higher by 9.56% on Monday, August 3rd, trading 0.2 times its typical volume. Mixed technical signals appeared with Stochastic Buy Signal and MACD Bullish Signal Line Cross suggesting upside potential, while 20 DMA Resistance indicated possible weakness — creating a conflicted technical picture. Key support levels exist at 0.1, 0.09 & 0.08, with resistance at 0.12, 0.14 & 0.15. Slow Stochastic readings suggest the stock is currently oversold.

Current SwingTradeBot Technical Rating of LIMN: F

Don’t miss other key signals LIMN triggered—view them now on SwingTradeBot.com.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: